Board of Directors

GLG's strong, active and independent Board of Directors is charged with the general oversight of officers and employees to ensure that performance is in the best interest of our shareholders. Our team is committed to long term growth, profitability and performance.

Dr. Luke Zhang, Chairman and Chief Executive Officer

With over 30 years of experience, Dr. Luke Zhang is a recognized individual in the business, medical and academic communities in both North America and Asia. He has successfully built and managed a number of firms in the health industry, food industry, medical equipment and software development industries.

He holds a Ph. D. in Pharmacology from Vanderbilt University in the United States, a Masters of Science in Pharmaceutical Chemistry from Shanghai First Medical University in China and a Bachelor of Medicine from Shandong Medical University in China.

His expertise in the medical field have helped fuel company growth as well as set foundational principals in research and innovation. In addition, his vision and strategic direction have enabled the company to maintain a leading edge in the global community.

Brian Palmieri, Vice Chairman

Brian Palmieri is a hands-on executive with extensive international business experience. As principal and CEO of multiple ventures, he has successfully built global corporations in manufacturing, services, and importing/exporting. He particularly specializes in start up and company restructuring, focusing on long term growth plans and profitability.

His aggressive entrepreneurship over the last 25 years has led him to all regions of the world including Europe, Asia, Africa and the Middle East. He has expertise in business development, operations, acquisitions, strategic alliances, and financing.

Currently, he is positioning GLG for global growth into markets outside of Asia.

Sophia Leung, Independent Director

Madame Sophia Leung, C.M. has made significant contributions to the business and political communities in Canada. Her various awards and achievements have reached the provincial as well as national level. Additionally, she has played an active role in the international business community, specifically in China, and has in turn also received international honors. The following is an overview of her accomplishments.

  • Special Advisor to Prime Minister of Canada in International Trade 2004-2006
  • Honorary President, Shenzhen Chamber of International Investment and Financing 2006-2008
  • Parliamentary Secretary for National Revenue of Canada 2000-2004
  • Member of Parliament of Canada 1997–2004
  • Chair, British Columbia Liberal Caucus
  • Chair, Northern and Western Liberal Caucus
  • Member, Standing Committee of Finance/Citizenship and Immigration in Parliament
  • Founding Chair, the Canada- Hong Kong Parliamentary Friendship Group
  • Vice-Chair, the Canada-China Legislative Friendship Association
  • YWCA Women of Distinction
  • Canada Volunteer Award
  • Order of Canada
  • Queen Elizabeth II Golden Jubilee Medal
  • Prime Minister’s Citation
Fangzhen He, Independent Director

Mr. Fangzhen He is a specialist in manufacturing and production. With over 40 years of experience, his rich expertise as a chief engineer lies in optimizing manufacturing plant and personnel, particularly in China. His specialties include planning, operational structure, maintenance, safety, quality control and risk management as well as the assignment, training and supervision of production and technology personnel. Mr. He graduated from Taiyuan Polytech University in China.

Yingchun Liu, Independent Director

Ms. Liu Yingchun has extensive experience in finance and accounting. Her most recently held positions include Credit Director for the Heze Industrial and Commercial Bank and Division Director for Pacific Life Insurance in Heze, China.

David Hall, Independent Director

Mr. David Hall is a consultant to the life sciences industry. He was previously the Chief Financial Officer and Chief Compliance Officer for Angiotech Pharmaceuticals, and is an active advocate for the British Columbia life sciences industry. During Mr. Hall's tenure with Angiotech, he helped facilitate $1.2 billion in financing, assisted in the completion of 11 acquisitions and established one of Canada's first dedicated SOX programs. Mr. Hall is the Past Chair and a current board member of Life Sciences BC, a non-profit advocacy group for biotechnology, where he actively leads the organization's public policy initiatives.

Mr. Hall was also a member of the BC Task Force on PharmaCare and serves on the board of directors of the International Finance Centre for British Columbia. Mr. Hall holds an Honours Economic and an Honours Finance degree from the University of Manitoba.

Dr. Hong Zhao Guang, Independent Director

Dr. Hong Zhao Guang is an active leader in both the academic and business communities in China. Receiving his degree from Shanghai First Medical College, he has been the vice president of Beijing Anzhen Hospital and the vice director of the Cardiovascular Disease Expert Consulting Committee for the Ministry of Public Health in China. Currently Dr. Hong is directing commissioner with the Aged Chinese Healthcare Association and the vice group leader for physicians at Capital Medical Science University, one of the top ranking academic medical institutions in China.

Dr. Hong has written and edited more than ten books and published more than one hundred academic theses and five hundred articles for the scientific community. During the last 15 years, Dr. Hong has devoted his time to the education of citizens throughout China on the importance of wellness, health, and an active lifestyle, including the prevention of diabetes and cardiovascular diseases. His books have been read by more than 70 million people and his lectures heard by over 200 million people in China.